Year |
Citation |
Score |
2009 |
Eddins D, Klein RC, Yakel JL, Levin ED. Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Research Bulletin. 79: 111-5. PMID 19185602 DOI: 10.1016/J.Brainresbull.2009.01.003 |
0.333 |
|
2008 |
Gay EA, Klein RC, Melton MA, Blackshear PJ, Yakel JL. Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide. The Journal of Pharmacology and Experimental Therapeutics. 327: 884-90. PMID 18812491 DOI: 10.1124/Jpet.108.144758 |
0.439 |
|
2006 |
Klein RC, Yakel JL. Functional somato-dendritic alpha7-containing nicotinic acetylcholine receptors in the rat basolateral amygdala complex. The Journal of Physiology. 576: 865-72. PMID 16931547 DOI: 10.1113/Jphysiol.2006.118232 |
0.318 |
|
2006 |
Gay EA, Klein RC, Yakel JL. Apolipoprotein E-derived peptides block alpha7 neuronal nicotinic acetylcholine receptors expressed in xenopus oocytes. The Journal of Pharmacology and Experimental Therapeutics. 316: 835-42. PMID 16249370 DOI: 10.1124/Jpet.105.095505 |
0.423 |
|
2005 |
Klein RC, Yakel JL. Paired-pulse potentiation of alpha7-containing nAChRs in rat hippocampal CA1 stratum radiatum interneurones. The Journal of Physiology. 568: 881-9. PMID 16141265 DOI: 10.1113/Jphysiol.2005.096081 |
0.307 |
|
2004 |
Klein RC, Yakel JL. Inhibition of nicotinic acetylcholine receptors by apolipoprotein E-derived peptides in rat hippocampal slices. Neuroscience. 127: 563-7. PMID 15283956 DOI: 10.1016/J.Neuroscience.2004.05.045 |
0.432 |
|
2003 |
Khiroug L, Giniatullin R, Klein RC, Fayuk D, Yakel JL. Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 9024-31. PMID 14534236 DOI: 10.1523/Jneurosci.23-27-09024.2003 |
0.315 |
|
2003 |
Klein RC, Prorok M, Castellino FJ. Direct binding properties of conantokins to native N-methyl-d-aspartate receptors. The Journal of Peptide Research : Official Journal of the American Peptide Society. 61: 307-17. PMID 12753378 DOI: 10.1034/J.1399-3011.2003.00059.X |
0.543 |
|
2001 |
Klein RC, Warder SE, Galdzicki Z, Castellino FJ, Prorok M. Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides. Neuropharmacology. 41: 801-10. PMID 11684144 DOI: 10.1016/S0028-3908(01)00119-8 |
0.709 |
|
2001 |
Klein RC, Castellino FJ. Activators and inhibitors of the ion channel of the NMDA receptor. Current Drug Targets. 2: 323-9. PMID 11554556 DOI: 10.2174/1389450013348290 |
0.52 |
|
2001 |
Klein RC, Prorok M, Galdzicki Z, Castellino FJ. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. The Journal of Biological Chemistry. 276: 26860-7. PMID 11335724 DOI: 10.1074/Jbc.M102428200 |
0.626 |
|
2001 |
Warder SE, Blandl T, Klein RC, Castellino FJ, Prorok M. Amino acid determinants for NMDA receptor inhibition by conantokin-T. Journal of Neurochemistry. 77: 812-22. PMID 11331410 DOI: 10.1046/J.1471-4159.2001.00281.X |
0.609 |
|
2001 |
Klein RC, Siarey RJ, Caruso A, Rapoport SI, Castellino FJ, Galdzicki Z. Increased expression of NR2A subunit does not alter NMDA-evoked responses in cultured fetal trisomy 16 mouse hippocampal neurons. Journal of Neurochemistry. 76: 1663-9. PMID 11259484 DOI: 10.1046/J.1471-4159.2001.00170.X |
0.52 |
|
1999 |
Klein RC, Galdzicki Z, Castellino FJ. Inhibition of NMDA-induced currents by conantokin-G and conantokin-T in cultured embryonic murine hippocampal neurons. Neuropharmacology. 38: 1819-29. PMID 10608277 DOI: 10.1016/S0028-3908(99)00065-9 |
0.627 |
|
1999 |
Klein RC, Castellino FJ. Inhibition of MK801 binding in adult rat brain sections by conantokin-G and conantokin-T. Neuroscience Letters. 273: 171-4. PMID 10515186 DOI: 10.1016/S0304-3940(99)00649-7 |
0.573 |
|
Show low-probability matches. |